Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Metastatic Non-small Cell Lung Cancers × amivantamab × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 8 Stomach Neoplasms 1 Salivary Gland Neoplasms 1 RAS/BRAF Wild-type Advanced Colorectal Cancer Patients 1 Neoplasms 1 Neoplasm Metastasis 1 Metastatic Non-small Cell Lung Cancers 1 Locally Recurrent Skin Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Carcinoma, Hepatocellular 1 Carcinoma, Adenoid Cystic 1

Interventions

lazertinib 1 amivantamab 1 Pemetrexed 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05299125 2025-10-01

AMIGO-1

Latin American Cooperative Oncology Group

Phase 2 Active not recruiting

Metastatic Non-small Cell Lung Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡